United States Ablation Devices Market Set to Reach USD 3.4 Billion by 2031 | Radiofrequency Ablation Leading with 38% Global Share

Market Size and Growth

The global Ablation Devices Market was valued at approximately USD 6.2 billion in 2024 and is projected to reach around USD 14.1 billion by 2033, expanding at a compound annual growth rate (CAGR) of 9.7% during the forecast period of 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/ablation-devices-market?Juli

Key Developments:

United States
✅ Expanded Approval for Pulsed‐Field Ablation
In July 2025, regulatory approval for pulsed-field ablation (PFA) systems was expanded to include treatment of persistent atrial fibrillation, beyond paroxysmal AF.

✅ Rapid Adoption of PFA Over Traditional Methods
Use of PFA devices for AF procedures is increasing, with PFA procedures now expected to comprise nearly half of AF ablations, while radiofrequency and cryoablation share decreases.

✅ Market Growth & Technology Trend
Minimally invasive ablation procedures continue to replace traditional surgery, supported by RF, cryo, laser, and PFA technologies. The U.S. market is a key driver of global growth, fueled by increasing preference for less invasive cardiac and non-cardiac ablation treatments.

Japan
✅ PFA Market Expansion
Japan is seeing growing adoption of pulsed-field ablation for cardiac arrhythmias, with new systems being approved or entering clinical use.

✅ Increased Clinical Activity in Electrophysiology
Minimally invasive procedures are gaining traction in hospitals across Japan, driving demand for advanced ablation devices.

✅ Technology Diversification
Adoption of RF, cryo, and PFA ablation systems is expanding to treat a wider range of indications, including oncology and cardiac disorders.

Market Segmentation:

➥By technology type, Radiofrequency Ablation (RFA) dominates the market with a 38% share (USD 3.36 billion), driven by widespread use in cardiac arrhythmias and oncology. Microwave Ablation (MWA) accounts for 15% (USD 1.33 billion), favored for faster heating and larger ablation zones in liver and lung tumors, while Cryoablation holds 14% (USD 1.24 billion) due to its precision in cardiac and renal tumor applications. High-Intensity Focused Ultrasound (HIFU) contributes 10% (USD 0.88 billion), growing in oncology and aesthetic procedures, and Laser Interstitial Thermal Ablation (LITA) represents 8% (USD 0.71 billion), mainly for brain and spinal tumors. Emerging technologies, including Pulsed-Field Ablation (PFA), hold 15% (USD 1.32 billion), reflecting rapid adoption in cardiac and oncology treatments.

➥By application type, cancer treatments dominate with 45% of the market (USD 3.98 billion), encompassing liver, lung, kidney, and brain tumors. Cardiovascular applications, primarily atrial fibrillation (AF) and other arrhythmias, represent 20% (USD 1.77 billion), benefiting from increasing PFA adoption. Ophthalmology accounts for 8% (USD 0.71 billion), urology for 7% (USD 0.62 billion), orthopedic applications 5% (USD 0.44 billion), and gynecology 5% (USD 0.44 billion), while other areas such as aesthetics and veterinary applications make up 10% (USD 0.88 billion).

➥In terms of function type, automated devices, including AI-assisted and robotic systems, capture 35% (USD 3.09 billion) of the market, primarily in developed regions, whereas conventional manual and semi-automated devices account for 65% (USD 5.75 billion), still prevalent in emerging markets.

➥Regarding procedure type, tumor ablation is the largest segment, with 40% (USD 3.54 billion), followed by atrial fibrillation procedures at 20% (USD 1.77 billion). Varicose vein ablation contributes 8% (USD 0.71 billion), aesthetic procedures for skin rejuvenation and tightening represent 12% (USD 1.06 billion), laser and other energy-based therapies account for 10% (USD 0.88 billion), and other emerging procedures make up the remaining 10% (USD 0.88 billion).

Competitive Landscape:
The major global players in the ablation devices market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Olympus Corporation, Stryker Corporation, Hologic, Inc., CONMED Corporation, Koninklijke Philips N.V., CooperSurgical, Inc. and among others.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=ablation-devices-market?Juli

Regional Insights:

North America dominates the market, accounting for approximately 40% of global revenue (USD 3.36 billion) in 2025. The growth is largely fueled by the United States, where advanced healthcare infrastructure, widespread adoption of RF, cryo, and pulsed-field ablation (PFA) technologies, and favorable reimbursement policies support strong demand in cardiac, oncology, and aesthetic applications.

Europe is the second-largest market, contributing around 25% (USD 2.21 billion). Growth in countries such as Germany, France, and the UK is driven by the modernization of cardiovascular care, increasing use of image-guided ablation, and expanding oncology applications. Adoption of minimally invasive and automated devices is accelerating, particularly in high-volume cardiac and tumor ablation centers.

Asia-Pacific is a rapidly expanding market, expected to reach roughly 20% (USD 1.77 billion) of global revenue in 2025, led by Japan, China, and India. Japan is a mature market with high adoption of PFA and RF technologies in cardiac and oncological applications, while emerging markets like China and India are witnessing strong growth due to increasing hospital infrastructure, rising awareness of minimally invasive procedures, and expanding healthcare coverage.

Latin America and Middle East & Africa together account for the remaining 17% (USD 1.50 billion). Growth in these regions is moderate but steady, driven by adoption in tertiary care hospitals and gradual penetration of minimally invasive technologies in oncology, cardiovascular, and aesthetic procedures.

Get Customized Report as per your Business Requirements: https://www.datamintelligence.com/customize/ablation-devices-market?Juli

Mergers & Acquisitions:

United States
✅ Strategic Acquisitions in Cardiac and Oncology Devices: Major U.S.-based medical technology companies, including Boston Scientific and Medtronic, have acquired niche ablation device startups specializing in pulsed-field ablation (PFA), cryoablation, and RF systems to accelerate adoption in cardiac arrhythmia and tumor ablation markets.

✅ Integration of Imaging and Navigation Technology: Some acquisitions focus on integrating AI-guided and image-guided procedural platforms into existing portfolios, enhancing precision, workflow efficiency, and clinical outcomes.

Japan & Asia-Pacific
✅ Collaborative Partnerships and Joint Ventures: Japanese companies like Olympus Corporation and Stryker Corporation have partnered with domestic technology firms to co-develop next-generation ablation solutions for cardiac, oncological, and minimally invasive surgical procedures.

✅ Global Expansion: Japan-based ablation device suppliers are collaborating with U.S. and European distributors to expand the reach of high-performance ablation technologies, particularly in oncology and cardiac care, across North America, Europe, and Asia-Pacific.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.